<DOC>
	<DOCNO>NCT00316602</DOCNO>
	<brief_summary>The purpose study compare immunogenicity safety investigational smallpox vaccine subject atopic dermatitis healthy volunteer .</brief_summary>
	<brief_title>A Phase II Study Immunogenicity Safety MVA-BN® ( IMVAMUNE™ ) Smallpox Vaccine Subjects With Atopic Dermatitis</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Smallpox</mesh_term>
	<criteria>Group 1 : Subjects without present history kind atopy . Group 2 : Subjects diagnose atopic dermatitis . All study subject : 1 . Male female subject 18 40 year age without history smallpox vaccination . 2 . Women must negative serum pregnancy test screen negative urine serum pregnancy test within 24 hour prior vaccination . 3 . Women childbearing potential must use acceptable method contraception 30 day prior first vaccination , must agree use acceptable method contraception study , must become pregnant least 28 day last vaccination . 4 . Lab value without clinically significant finding . 5 . Electrocardiogram ( ECG ) without clinically significant finding . 1 . Pregnant breastfeed woman . 2 . Uncontrolled serious infection i.e . respond antimicrobial therapy . 3 . History active autoimmune disease . Persons vitiligo thyroid disease take thyroid replacement exclude . 4 . Known suspected impairment immunologic function include , limited , clinically significant liver disease ; diabetes mellitus ; moderate severe kidney impairment . 5 . History malignancy , squamous cell basal cell skin cancer , unless surgical excision consider achieved cure . Subjects history skin cancer vaccination site exclude . 6 . History coronary heart disease , myocardial infarction , angina , congestive heart failure , cardiomyopathy , stroke transient ischemic attack , uncontrolled high blood pressure . 7 . History immediate family member ( father , mother , brother , sister ) onset ischemic heart disease age 50 year . 8 . Ten percent great risk develop myocardial infarction coronary death within next 10 year use National Cholesterol Education Program 's risk assessment tool : ( http : //hin.nhlbi.nih.gov/atpiii/calculator.asp ? usertype=prof ) NOTE : This criterion apply volunteer 20 year age old . 9 . History anaphylaxis severe allergic reaction . 10 . Post organ transplant subject whether receive chronic immunosuppressive therapy . 11 . Administration immunomodulatory substance .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Atopic dermatitis</keyword>
	<keyword>Smallpox</keyword>
	<keyword>Vaccination</keyword>
</DOC>